We are live on
!
Find out more
SRC
Stone Run Capital Portfolio holdings
AUM
$254M
1-Year Est. Return
12.86%
This Fund
S&P 500
This Quarter
Est. Return
+9.6%
1 Year Est. Return
+12.86%
3 Year Est. Return
+77.77%
5 Year Est. Return
+98.28%
10 Year Est. Return
+404.21%
AUM
$283M
AUM Growth
+$21.8M
(+8.3%)
Cap. Flow
-$926K
Cap. Flow
% of AUM
-0.33%
Top 10 Holdings %
Top 10 Hldgs %
37.55%
Holding
67
New
3
Increased
14
Reduced
21
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clarivate
CLVT
|
+$4.01M |
| 2 |
Walt Disney
DIS
|
+$2.56M |
| 3 |
Teleflex
TFX
|
+$1.04M |
| 4 |
Arista Networks
ANET
|
+$610K |
| 5 |
FISV
Fiserv Inc
FISV
|
+$564K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verisk Analytics
VRSK
|
+$3.39M |
| 2 |
Linde
LIN
|
+$1.53M |
| 3 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$1.21M |
| 4 |
Becton Dickinson
BDX
|
+$737K |
| 5 |
International Flavors & Fragrances
IFF
|
+$639K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.43% |
| 2 | Healthcare | 28.12% |
| 3 | Industrials | 15.06% |
| 4 | Materials | 14.55% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
AbbVie
ABBV
$443B
| $530K | 0.19% |
4,700
| – | – |
|
52
Canadian National Railway
CNI
$76.9B
| $506K | 0.18% |
4,800
| – | – |
|
53
Abbott
ABT
$183B
| $464K | 0.16% |
4,000
| – | – |
|
54
McDonald's
MCD
$192B
| $462K | 0.16% |
2,000
| – | – |
|
55
Johnson & Johnson
JNJ
$618B
| $453K | 0.16% |
2,750
| – | – |
|
56
Fortive
FTV
$17.9B
| $374K | 0.13% |
7,118
| – | – |
|
|
KSU
57
DELISTED
Kansas City Southern
KSU
| $340K | 0.12% |
1,200
| – | – |
|
58
Amgen
AMGN
$208B
| $329K | 0.12% |
1,350
| – | – |
|
59
Oneok
OKE
$57.2B
| $303K | 0.11% |
5,450
| – | – |
|
60
Charles River Laboratories
CRL
$11.2B
| $284K | 0.1% |
+769
| New | +$257K |
|
61
Brookfield Infrastructure
BIPC
$5.2B
| $278K | 0.1% |
5,520
-500
| -8% | -$24.1K |
|
62
Dominion Energy
D
$60.8B
| $257K | 0.09% |
3,500
| – | – |
|
|
ABST
63
DELISTED
Absolute Software Corp
ABST
| $255K | 0.09% |
17,600
+100
| +0.6% | +$1.42K |
|
64
Duke Energy
DUK
$97.8B
| $237K | 0.08% |
2,399
-88
| -4% | -$8.84K |
|
65
GE Aerospace
GE
$374B
| – | – |
-2,143
| Closed | -$140K |
|
66
Merck
MRK
$322B
| – | – |
-6,257
| Closed | -$461K |
|
|
VAR
67
DELISTED
Varian Medical Systems, Inc.
VAR
| – | – |
-6,835
| Closed | -$1.21M |
|
Similar funds
TCB
OIA
SSW
JSP
WS
MTWM
KSWA
GA
Stone Run Capital's Q2 2021 Portfolio in Review
As of Q2 2021, Stone Run Capital held 67 positions worth $283M, up 8.3% from $262M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Stone Run Capital's Q2 2021 filing shows 3 new, 14 increased, 21 reduced and 3 closed positions. Its largest new stake was Clarivate: 145,800 shares worth $4.01M. The largest sale was Verisk Analytics, an estimated $3.39M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.
- Stone Run Capital's largest Q2 2021 buy was Clarivate: 145,800 shares worth $4.01M.
- Stone Run Capital added most to Teleflex in Q2 2021, an estimated $1.04M increase.
- Stone Run Capital's biggest Q2 2021 reduction was Verisk Analytics, cutting an estimated $3.39M.
- Stone Run Capital fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.21M.
- Stone Run Capital's ten largest holdings make up 38% of its $283M portfolio in Q2 2021.
- Stone Run Capital opened 3 new positions and closed 3 in Q2 2021.
- Stone Run Capital's portfolio value rose 8.3% quarter-over-quarter to $283M.
Based on Stone Run Capital's 13F filing for Q2 2021, filed 16 Aug 2021.